FR2019845A1 - Anti depressant compositions which increase the 5 - hydroxytryptophane concentration - Google Patents

Anti depressant compositions which increase the 5 - hydroxytryptophane concentration

Info

Publication number
FR2019845A1
FR2019845A1 FR6933840A FR6933840A FR2019845A1 FR 2019845 A1 FR2019845 A1 FR 2019845A1 FR 6933840 A FR6933840 A FR 6933840A FR 6933840 A FR6933840 A FR 6933840A FR 2019845 A1 FR2019845 A1 FR 2019845A1
Authority
FR
France
Prior art keywords
tryptophane
laevorotatory
hydroxytryptophane
concentration
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR6933840A
Other languages
English (en)
French (fr)
Other versions
FR2019845B1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAMBRIAN CHEMICALS Ltd
Original Assignee
CAMBRIAN CHEMICALS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAMBRIAN CHEMICALS Ltd filed Critical CAMBRIAN CHEMICALS Ltd
Publication of FR2019845A1 publication Critical patent/FR2019845A1/fr
Application granted granted Critical
Publication of FR2019845B1 publication Critical patent/FR2019845B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR6933840A 1968-10-03 1969-10-03 Anti depressant compositions which increase the 5 - hydroxytryptophane concentration Granted FR2019845A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4704268 1968-10-03
GB266069 1969-01-16

Publications (2)

Publication Number Publication Date
FR2019845A1 true FR2019845A1 (en) 1970-07-10
FR2019845B1 FR2019845B1 (ja) 1973-01-12

Family

ID=26237645

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6933840A Granted FR2019845A1 (en) 1968-10-03 1969-10-03 Anti depressant compositions which increase the 5 - hydroxytryptophane concentration

Country Status (7)

Country Link
BE (1) BE739613A (ja)
CA (1) CA934663A (ja)
DE (1) DE1949774A1 (ja)
ES (1) ES372150A1 (ja)
FR (1) FR2019845A1 (ja)
IE (1) IE33333B1 (ja)
NL (1) NL6914820A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039384A1 (en) * 2002-11-01 2004-05-13 Hudson Susan P Sexual desire and performance enhancement with meal from plants containing protein-bound tryptophan

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089948B1 (en) * 1981-10-05 1985-08-14 COPPEN, Alec James Pharmaceutical compositions
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039384A1 (en) * 2002-11-01 2004-05-13 Hudson Susan P Sexual desire and performance enhancement with meal from plants containing protein-bound tryptophan

Also Published As

Publication number Publication date
DE1949774A1 (de) 1970-05-27
IE33333B1 (en) 1974-05-29
NL6914820A (ja) 1970-04-07
BE739613A (ja) 1970-03-02
ES372150A1 (es) 1971-12-16
IE33333L (en) 1970-04-03
CA934663A (en) 1973-10-02
FR2019845B1 (ja) 1973-01-12

Similar Documents

Publication Publication Date Title
SE7903817L (sv) Moranolinderivat
IL41784A0 (en) Novel optically active derivatives of 1-phenyl-2-aminoethanol,their preparation and pharmaceutical compositions containing them
ES352030A1 (es) Procedimiento de obtencion y purificacion de la uricasa.
NL150096B (nl) Werkwijze voor het bereiden van gesubstitueerde (alpha)-fenoxycarbonzuurderivaten met cholesterol- of lipidegehalte verlagende werking, werkwijze voor het bereiden van een therapeutisch preparaat en gevormd therapeutisch preparaat.
FR2019845A1 (en) Anti depressant compositions which increase the 5 - hydroxytryptophane concentration
ES343957A1 (es) Procedimiento de obtencion de polisacaridos sulfatados an- tilipemicos activos por via oral.
ES364982A1 (es) Un procedimiento para la elaboracion de un preparado de hierro oral.
DK128052B (da) Fremgangsmåde til fremstilling af enhedsdoser i fast tilstand af lægemidler under anvendelse af sukker som bærestof.
FR2086292A1 (en) 3-quinuclidinone oxime carbamates - with insecticidal and acaricidal activity
GB904955A (en) Pharmaceutical compositions containing phloroglucinol
IL34747A0 (en) Ergonorcornine,its 1-methyl derivative and their salts,their preparation and pharmaceutical compositions containing them
ES377523A1 (es) Un procedimiento para fabricar una sustancia combinada, compuesta de acido germanico y cisteina.
Kang et al. Effects of X-irradiation on the Oxygen Consumption and Lysine Uptake of HeLa Cells in the Presence of Metabolic Substrates and Inhibitors
USD205548S (en) Package for medicament tablets or the like
USD224000S (en) Storefront
BE588740A (fr) Procédé de préparation de nouveaux aza-composés, notamment de tertio(inférieur)-amino-alcoyl (inférieur)-7-aza-benzimidazoles et de leurs sels.
FR2305194A1 (fr) Composition enzymatique effervescente
CA792767A (en) Monohydrate of the equimolecular complex of ascorbic acid and pyridoxine base, and process for its preparation
GB908076A (en) Fibrinolytic compositions suitable for buccal administration
YU57171A (en) Process for obtaining optically active bicycloalkane derivatives
JPS5290687A (en) Highly active glucoseisomerase concentrate having high storage stabili ty
NL165147C (nl) Werkwijze ter bereiding van een tegen ontsteking, koorts en pijn werkzaam preparaat, dat als actieve stof een fenoxyfenylalkaancarbonzuur of derivaat daarvan bevat,alsmede werkwijze ter bereiding van fenoxy- fenylalkaancarbonzuren en derivaten daarvan.
FR2099449A1 (en) Tetracycline 3,4,5-trimethoxybenzoate trihydrate - a stable tasteless salt of tetracycline with similar activity
CA910194A (en) Compositions containing physiologically active kawa compounds, process of making same, and method of using same in therapy
NL149810B (nl) Werkwijze ter bereiding van een farmaceutisch preparaat door kristallijn cefalexine in een voor therapeutische toediening geschikte vorm te brengen, gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van voor bovengenoemde toepassing geschikt cefalexine.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse